| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1368580 | Bioorganic & Medicinal Chemistry Letters | 2016 | 5 Pages |
Abstract
A series of novel aryloxyphosphoramidate nucleoside prodrugs based on l-aspartic acid and l-glutamic acid as amino acid motif has been synthesized and evaluated for antitumoral activity. Depending on the cancer cell line studied and on the nature of the parent nucleoside compound (gemcitabine, 5-iodo-2′-deoxy-uridine, floxuridine or brivudin), the corresponding ProTides are endowed with an improved or decreased cytotoxic activity.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Ling-Jie Gao, Steven De Jonghe, Dirk Daelemans, Piet Herdewijn,